MicroRNA-Based Diagnosis and Therapy

• Published in: International journal of molecular sciences Vol. 23; no. 13; p. 7167
• Main Authors: Ho, Phuong T. B., Clark, Ian M., Le, Linh T. T.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 28.06.2022; MDPI
• Subjects: Biomarkers; Biosynthesis; Cancer therapies; Clinical medicine; Colorectal cancer; Cytoplasm; Disease; Gastric cancer; Gene expression; Immune system; Liver cancer; MicroRNAs; Patients; Plasma; Proteins; Review; RNA polymerase; Telomerase
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23137167

MicroRNAs (miRNAs) are a group of endogenous non-coding RNAs that regulate gene expression. Alteration in miRNA expression results in changes in the profile of genes involving a range of biological processes, contributing to numerous human disorders. With high stability in human fluids, miRNAs in the circulation are considered as promising biomarkers for diagnosis, as well as prognosis of disease. In addition, the translation of miRNA-based therapy from a research setting to clinical application has huge potential. The aim of the current review is to: (i) discuss how miRNAs traffic intracellularly and extracellularly; (ii) emphasize the role of circulating miRNAs as attractive potential biomarkers for diagnosis and prognosis; (iii) describe how circulating microRNA can be measured, emphasizing technical problems that may influence their relative levels; (iv) highlight some of the circulating miRNA panels available for clinical use; (v) discuss how miRNAs could be utilized as novel therapeutics, and finally (v) update those miRNA-based therapeutics clinical trials that could potentially lead to a breakthrough in the treatment of different human pathologies.